These findings suggested that the major cause of macular edema alleviation in the short-term treatment of DME by anti-VEGF could be the alleviation of retinal vascular exudation, while the retinal vascular occlusion did not significantly improve; nevertheless, the perfusion defect in macular vessels also did not worsen. Here, VEGFA is linked to vascular occlusion disorder.